Cue Biopharma
89 hedge funds and large institutions have $246M invested in Cue Biopharma in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 30 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 30
5.5% less ownership
Funds ownership: 59.11% → 53.61% (-5.5%)
Holders
89
Holding in Top 10
2
Calls
$1.73M
Puts
$745K
Top Buyers
| 1 | +$1.51M | |
| 2 | +$1.36M | |
| 3 | +$1.25M | |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$776K |
| 5 |
Morgan Stanley
New York
|
+$683K |
Top Sellers
| 1 | -$7.85M | |
| 2 | -$5.57M | |
| 3 | -$2.38M | |
| 4 |
Goldman Sachs
New York
|
-$2.33M |
| 5 |
Millennium Management
New York
|
-$2.14M |